Imaging & Diagnostics

As 2024 recedes into the annals of history, the spotlight on artificial intelligence (AI) in the medtech industry has only grown brighter. Major players like GE Healthcare, Medtronic, and Dexcom have introduced new AI features, while companies such as Stryker and Quest Diagnostics have expanded

In recent years, the anticipated surge in dementia diagnoses in the United States has been a growing concern among medical professionals. Projections indicate that the number of dementia cases is expected to double over the next four decades, potentially surpassing one million new cases annually.

In a groundbreaking development in medical imaging, Bayer has introduced a new gadolinium-based contrast agent (GBCA) known as gadoquatrane, which has demonstrated the capability to use 60% less gadolinium compared to traditional agents while maintaining high imaging quality. This innovation is

The article explores the deployment of on-premise AI technologies by the startup ALAFIA Supercomputers, with a specific focus on the healthcare industry. The subject of analysis is how ALAFIA’s advanced hardware enhances AI applications in medical imaging, thoroughly examining how improved c

In recent years, the medical field has seen significant advancements with the integration of technology, particularly artificial intelligence (AI) and robotics. One of the most promising areas of development is the use of AI and robotic systems to revolutionize CT-guided biopsy procedures.

The unveiling of the new MRI suite at Erie Shores HealthCare marks a significant advancement in healthcare services for Leamington, Ontario, and its surrounding regions. This state-of-the-art facility, funded partly by the province of Ontario, promises to enhance diagnostic capabilities, reduce